Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group-Reference-Cited by-同舟云学术

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

Published:2004-08 Issue:2 Volume:94 Page:483-487
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Muggia Franco M,Blessing John A,McGehee Ramon,Monk Bradley J

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference22 articles.

1. Cisplatinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group;Thigpen;Cancer,1981

2. Chemoradiation for locally advanced cervical cancer; does it help?;Rose;J. Clin. Oncol.,2002

3. A randomized study of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Omura;J. Clin. Oncol.,1997

4. A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Moore;Proc. Am. Soc. Clin. Oncol.,2001

5. Phase II study of irinotecan in prior chemotherapy treated squamous cell carcinoma of the cervix;Verschraegen;J. Clin. Oncol.,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers;Frontiers in Oncology;2017-04-04

2. Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates;F1000Research;2015-07-13

3. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation;International Journal of Hyperthermia;2013-10-24

4. Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010;Gynecologic Oncology;2013-10

5. Developments in the systemic treatment of metastatic cervical cancer;Cancer Treatment Reviews;2013-08